TNF and rheumatoid arthritis: In conclusion, although we can generate iTH+ cells from ASCs, which can be a future platform for autologous cell therapy with these cells in RA, TNF and possibly other proinflammatory cytokines in synovial tissue and fluid might disturb the antiinflammatory role of these cells.